ContraVir Pharma

CTRV NASDAQ
3.674
+0.024
+0.66%
交易中 11:50 07/18 EDT
开盘
3.660
昨收
3.650
最高
3.791
最低
3.650
成交量
4.70万
成交均量(3M)
83.74万
52周最高
91.00
52周最低
3.520
换手率
5.86%
市值
294.95万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供ContraVir Pharma CTRV股票价格,ContraVir Pharma股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

ContraVir Pharmaceuticals, Inc. is focused on curing hepatitis B through the combination of direct and indirect acting antiviral compounds. Its two assets tenofovir exalidex, or TXL, and CRV431 have complementary mechanisms of action and have shown potential synergy against hepatitis B virus (HBV). TXL is designed to deliver high intrahepatic concentrations of TFV while minimizing off target effects caused by high levels of circulating TFV, and has completed a Phase IIa trial. CRV431, the other anti-HBV compound, is a next generation cyclophilin inhibitor with a unique structure that increases its potency and selective index against HBV. In vitro and in vivo studies have thus far demonstrated that CRV431 reduces HBV DNA and other viral proteins, including surface antigen (HBsAg).
展开 >

最近浏览

名称
价格
涨跌幅